Sai Life Sciences is a full-service CRO-CDMO driven by a vision to support the launch of 25 new medicines by 2025. It works with innovator pharma and biotech companies globally, accelerating the discovery, development, and manufacture of complex small molecules. As a pure-play CRO-CDMO, Sai Life Sciences has served diverse NCE development programs, consistently delivering value based on its quality and responsiveness. Today, it works with 7 of the top 10 large pharma companies, as well as several small and mid-sized pharma & biotech companies. Sai Life Sciences is privately held and backed by global investors, TPG Capital and HBM Healthcare Investments.
Shared 3 months ago
150 views
Shared 3 months ago
74 views
Shared 3 months ago
29 views
Shared 3 months ago
45 views
Shared 3 months ago
91 views
Shared 3 months ago
41 views
Shared 3 months ago
35 views
Shared 3 months ago
29 views
Shared 3 months ago
228 views
Shared 1 year ago
280 views
Shared 4 years ago
9.8K views
Shared 4 years ago
1.6K views
Shared 4 years ago
4.3K views
Shared 4 years ago
2.4K views
Shared 4 years ago
701 views
Shared 4 years ago
1.4K views
Shared 4 years ago
1.4K views
Shared 4 years ago
2.1K views
Shared 4 years ago
790 views
Shared 4 years ago
1.2K views
Shared 4 years ago
1.7K views
Shared 4 years ago
1.1K views
Shared 4 years ago
298 views
Shared 4 years ago
812 views
Shared 4 years ago
211 views
Shared 4 years ago
342 views
Shared 4 years ago
1.3K views
Shared 4 years ago
658 views
Shared 4 years ago
825 views
Shared 4 years ago
145 views
Shared 5 years ago
294 views
Shared 5 years ago
159 views
Shared 5 years ago
3.6K views
Shared 5 years ago
2.6K views
Shared 5 years ago
1.5K views
Shared 5 years ago
435 views
Shared 5 years ago
539 views
Shared 5 years ago
437 views
Shared 5 years ago
1.9K views
Shared 5 years ago
193 views
Shared 5 years ago
584 views
Shared 6 years ago
659 views
Shared 6 years ago
14K views
Shared 6 years ago
1K views
Shared 6 years ago
11K views
